PANoptosomes are involved in many diseases including autoinflammatory, metabolic & neurodegenerative diseases, cancer & microbial human infections.
PANoptosis – Inflammatory Cell Death
Non-Animal Source Multiclonal Recombinant Secondary Antibodies
MULTICLONALS are recombinant secondary antibodies developed by AdipoGen’s innovative partner Abcalis.
FNDC5/Irisin & FNDC4 – Members of the FNDC Protein Family
AdipoGen Life Sciences offers a broad range of FNDC4, FNDC5 and Irisin research reagents, including Recombinant Proteins, Antibodies and ELISA Kits.
SURAMIN – A Multifunctional Small Molecule with over 100 Years of History
Suramin is a multifunctional molecule with a wide array of potential applications, from parasitic and viral diseases to cancer, snakebite and autism.
Resiniferatoxin (RTX) – Potent TRPV1 Agonist for Pain Relief
The plant Euphorbia resinifera contains the most potent irritant known so far. It was isolated and identified as resiniferatoxin (RTX).
Manumycin A – Exosome Biogenesis Inhibitor
Manumycin A is an inhibitor of exosome biogenesis & secretion. Targeting exosome biogenesis could exert RAS signalling inhibitors’ anticancer effects.
Nano Vaccines Induce T Cell Immunity and Control of Tumour Growth
Using nanoparticle technology in making vaccines for infectious diseases/cancer is advancing & enhances the immunogenicity of some vaccine candidates.
LEADGENE® Indoxyl Sulfate ELISA Kit: Rapid Detection and Surveillance of Chronic Kidney Disease
LEADGENE® Indoxyl Sulfate ELISA Kit is the first CE-registered antibody-based assay tool for chronic kidney disease (CKD) on the global market.
Leadgene Utilizes LEADSPHERE™ Lyophilization Technology to Make Reagents Stable for Long-Term Logistics – Press release
Leadgene Biomedical has announced the launch of LEADSPHERE™ Lyophilization Technology to aid in the dispense, storage, and transport of their reagents
Popular Targets for Bispecific Antibody Drugs
Bispecific Antibody drugs gained popularity since approval of blinatumomab. 6 bsAb drugs are approved by the US FDA/EMA & 180+ are in clinical trials.